Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bone Disorders

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...

Skeletal Muscle Relaxants: Adverse Effects

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...

Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids

Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids

In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...

Peptic Ulcer Disease IV: Management

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...

What is the Skeletal System?

What is the Skeletal System?

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

MRI and Ultrasound in giant cell arteritis: complementary strengths and combined diagnostic value.

Seminars in arthritis and rheumatism·2026

Same author

Risk stratification for renal outcomes in ANCA-associated vasculitides using established scores and histopathological criteria.

Journal of nephrology·2026

Same author

Impact of Kidney Histology and Choice of Treatment on Survival in Patients with Multiple Myeloma.

Kidney360·2026

Same author

Prediction of relapses in patients with small vessel vasculitides: a multicenter cohort study on histopathological risk patterns.

Rheumatology international·2025

Same author

A fluconazole population pharmacokinetics study to improve target attainment in critically ill patients.

Infection·2025

Same author

New versus old: comparison of the 2022 ACR/EULAR versus the 1990 ACR classification criteria for giant cell arteritis in a real-world cohort.

Rheumatology international·2025

Search research articles

Related Experiment Videos

Adverse effects of bisphosphonates: current issues.

Ingo J Diel¹, Raoul Bergner, Knut A Grötz

¹Institute for Gynecological Oncology, Mannheim, Germany. ingo.diel@cgg-mannheim.de

The Journal of Supportive Oncology

|February 5, 2008

Summary

Bisphosphonates manage bone metastases in cancer patients. Careful selection is key, considering varying adverse effects like renal toxicity, GI issues, and osteonecrosis of the jaw (ONJ) for optimal patient care.

Related Experiment Videos

Area of Science:

Oncology
Pharmacology
Bone Metastasis Management

Background:

Bisphosphonates are crucial palliative treatments for metastatic bone disease.
Patient quality of life and adverse effect profiles are key management considerations.

Purpose of the Study:

To review the adverse effect profiles of commonly used bisphosphonates.
To inform the selection of bisphosphonates based on patient characteristics and preferences.

Main Methods:

Review of adverse event data for clodronate, pamidronate, zoledronic acid, and ibandronate.
Comparison of renal toxicity, acute-phase reactions, gastrointestinal (GI) toxicity, and osteonecrosis of the jaw (ONJ) incidence.

Main Results:

Zoledronic acid and pamidronate carry risks of renal toxicity.
Intravenous ibandronate and oral bisphosphonates show renal safety comparable to placebo.
Acute-phase reactions are associated with intravenous aminobisphosphonates; GI effects with oral agents.
Osteonecrosis of the jaw (ONJ) is an emerging complication with unknown incidence.

Conclusions:

Bisphosphonate adverse effect profiles vary significantly.
Individual patient factors are essential when choosing a bisphosphonate for metastatic bone disease.